All patients underwent pretreatment examination using a 64-slice MDCT. Computed tomography (CT) was performed according to a defined pancreas protocol as 4-phasic contrast-enhanced MDCT with thin slices at intervals of 1 mm. In the present study, all of these 100 patients were reclassified into the 3 groups (R, BR, and UR) according to NCCN guidelines (2010)7 based on MDCT findings at the initial visit to our hospital. The CT criteria of the NCCN guidelines are as follows: R criteria, (1) no evidence of SMV and PV abutment, distortion, tumor thrombus, or venous encasement and (2) clear fat planes around the CA, hepatic artery, and SMA; BR criteria, (1) venous involvement of the PV/SMV demonstrating tumor abutment without impingement and narrowing of the lumen, encasement of the PV/SMV without encasement of the nearby arteries, or short-segment venous occlusion resulting from either tumor thrombus or encasement but with suitable vessel proximal and distal to the area of vessel involvement, allowing for safe resection and reconstruction, (2) gastroduodenal artery encasement up to the hepatic artery with either short-segment encasement or direct abutment of the hepatic artery without extension to the CA, and (3) tumor abutment of the SMA not exceeding greater than 180° of the circumference of the vessel wall; and UR criteria, (1) greater than 180° of SMA encasement, celiac involvement (any abutment of the head with a greater than 180° encasement of the body or tail), (2) unreconstructive PV/SMV occlusion, and (3) aortic invasion. On the basis of the objective CT criteria, the patients enrolled in our study were classified as follows: 14 patients with R, 44 with BR, and 42 with UR tumors.
Gemcitabine-Based Chemoradiotherapy for Locally Advanced Pancreatic Cancer
All patients underwent pretreatment examination using a 64-slice MDCT. Computed tomography (CT) was performed according to a defined pancreas protocol as 4-phasic contrast-enhanced MDCT with thin slices at intervals of 1 mm. In the present study, all of these 100 patients were reclassified into the 3 groups (R, BR, and UR) according to NCCN guidelines (2010)7 based on MDCT findings at the initial visit to our hospital. The CT criteria of the NCCN guidelines are as follows: R criteria, (1) no evidence of SMV and PV abutment, distortion, tumor thrombus, or venous encasement and (2) clear fat planes around the CA, hepatic artery, and SMA; BR criteria, (1) venous involvement of the PV/SMV demonstrating tumor abutment without impingement and narrowing of the lumen, encasement of the PV/SMV without encasement of the nearby arteries, or short-segment venous occlusion resulting from either tumor thrombus or encasement but with suitable vessel proximal and distal to the area of vessel involvement, allowing for safe resection and reconstruction, (2) gastroduodenal artery encasement up to the hepatic artery with either short-segment encasement or direct abutment of the hepatic artery without extension to the CA, and (3) tumor abutment of the SMA not exceeding greater than 180° of the circumference of the vessel wall; and UR criteria, (1) greater than 180° of SMA encasement, celiac involvement (any abutment of the head with a greater than 180° encasement of the body or tail), (2) unreconstructive PV/SMV occlusion, and (3) aortic invasion. On the basis of the objective CT criteria, the patients enrolled in our study were classified as follows: 14 patients with R, 44 with BR, and 42 with UR tumors.
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Mie University
Protocol cited in 6 other protocols
Variable analysis
- Tumor Classification (R, BR, UR)
- Treatment protocol (gem-CRTS)
- Development of distant metastases after gem-CRT treatment
- Patients with PDAC who were diagnosed as having UICC-T3 and UICC-T4 tumors using multidetector computed tomography (MDCT)
- Patients who gave written informed consent for inclusion in the study
- Diagnosis of pancreatic cancer confirmed by means of cytological or histological analysis of biopsy specimens obtained using endoscopic ultrasonography–guided fine-needle aspiration (EUS-FNA)
- Patients excluded when the tumor extension determined by MDCT was categorized as UICC-T1 or UICC-T2 and/or when they showed evident distant metastatic lesions
- Study protocol approved by the medical ethics committee of Mie University
- Study performed in accordance with the ethical standards established in the 1964 Declaration of Helsinki
- All patients underwent pretreatment examination using a 64-slice MDCT with defined pancreas protocol as 4-phasic contrast-enhanced MDCT with thin slices at intervals of 1 mm
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!